A revenue-generating, small-cap Canadian pharmaceutical company
Revenue Projected at $150,000,000 by 2025
fast facts
- name Valeo Pharma Inc.
- symbol VPH
- exchange TSX
- financials View Filings
- shares outstanding 80,661,530 as of 04/30/2022
- industry Technology & Medical
- transfer agent Computershare Investor Services Inc.
- website https://www.valeopharma.c...
recent updates
most recent messages
top rated messages